🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial studies how well venetoclax and ibrutinib work in treat...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2016-07-07
Trial ID
NCT02756897
Treatments Being Tested
This phase Ib/II trial studies the best dose and safety of Bcl-2 inhibitor ...
Status
Active Not Recruiting
Location
Ohio State University Comprehensive Cancer Center
Start Date
2015-08-03
Trial ID
NCT02427451
This is a phase 2, open-label, multicenter study evaluating the efficacy an...
Status
Not Yet Recruiting
Location
Institut Jules Bordet
Start Date
2026-12-31
Trial ID
NCT07738887
Treatments Being Tested
The purpose of this study is to determine the optimal dosing scheme for the...
Status
Completed
Location
City of Hope
Start Date
2015-04
Trial ID
NCT02419560
Treatments Being Tested
Background: Bruton s tyrosine kinase inhibitors (BTKi) are used to treat a...
Status
Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2023-03-01
Trial ID
NCT05724121
This study looks at how often atrial fibrillation (AF), an irregular heart ...
Status
Not Yet Recruiting
Location
City of Hope
Start Date
2026-08
Trial ID
NCT07711327
This phase III trial compares adding a new anti-cancer drug (venetoclax) to...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2019-01-31
Trial ID
NCT03737981
Treatments Being Tested
The purpose of this study is to test the safety of Venetoclax in combinatio...
Status
Completed
Location
Memorial Sloan Kettering Basking Ridge
Start Date
2017-09-20
Trial ID
NCT03295240
Treatments Being Tested
Phase 2, two cohort trial evaluating the addition of ublituximab and umbral...
Status
Terminated
Location
TG Therapeutics Investigational Trial Site
Start Date
2019-08-05
Trial ID
NCT04016805
Treatments Being Tested
The purpose of this study is to see how well Ibrutinib and Venetoclax (I+V)...
Status
Recruiting
Location
Spitalul Universitar de Urgenta Bucuresti
Start Date
2026-05-18
Trial ID
NCT07602088